CARLOMAGNO, FRANCESCA
CARLOMAGNO, FRANCESCA
DIPARTIMENTO DI MEDICINA MOLECOLARE E BIOTECNOLOGIE MEDICHE
Drug insight: Small-molecule inhibitors of protein kinases in the treatment of thyroid cancer.
2006 Santoro, Massimo; Carlomagno, Francesca
Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma
2002 F., Basolo; R., Giannini; C., Monaco; Melillo, ROSA MARINA; Carlomagno, Francesca; M., Pancrazi; G., Salvatore; G., Chiappetta; F., Pacini; R., Elisei; P., Miccoli; A., Pinchera; Fusco, Alfredo; Santoro, Massimo
The Insulin Receptor Substrate (IRS)-1 recruits Phosphatidylinositol 3-Kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to Ret.
2001 Melillo, ROSA MARINA; Carlomagno, Francesca; DE VITA, Gabriella; Formisano, Pietro; Vecchio, Giancarlo; Fusco, Alfredo; Billaud, M.; Santoro, Massimo
I geni oncosoppressori in "Patologia Generale" IV Ed, Pontieri-Russo-Frati
2009 Santoro, Massimo; Carlomagno, F; Vecchio, Giancarlo
Basi molecolari delle nuove terapie: inibitori delle protein-chinasi.
2007 Santoro, Massimo; Salvatore, G.; Carlomagno, F.; Fusco, Alfredo
Activation of RET oncogene and thyroid carcinogenesis
1993 Santoro, Massimo; Grieco, M.; Melillo, ROSA MARINA; Carlomagno, F.; Cerrato, A.; Sabino, N.; Battaglia, C.; Fusco, Alfredo; Vecchio, Giancarlo
RET\PTC activation in human thyroid carcinomas
1995 Fusco, Alfredo; Santoro, Massimo; Grieco, M.; Carlomagno, Francesca; Dathan, N.; Fabien, N.; Berlingieri, M. T.; Li, Z.; de franciscis, V.; Salvatore, Domenico; Melillo, ROSA MARINA; Portella, Giuseppe; Cerrato, A.; Colantuoni, V.; Vecchio, Giancarlo
Molecular Mechianism of RET Activation In Human Neoplasia
2002 Santoro, Massimo; Carlomagno, F.; Melillo, ROSA MARINA; Vecchio, Giancarlo; Fusco, Alfredo
Molecular mechanisms of RET activation in human cancer.
2002 Santoro, Massimo; Melillo, ROSA MARINA; Carlomagno, Francesca; Fusco, Alfredo; Vecchio, Giancarlo
Attacking cancer with molecularly targeted agents
2013 Santoro, Massimo; Carlomagno, Francesca
Oncogenic rearrangements driving ionizing radiation-associated human cancer
2013 Santoro, Massimo; Carlomagno, Francesca
Structure prediction and validation of the ERK8 kinase domain.
2013 Strambi, A; Mori, M; Rossi, M; Colecchia, D; Manetti, F; Carlomagno, Francesca; Botta, M; Chiariello, M.
NCOA4 inhibits initiation of DNA replication to maintain genome stability
2012 Bellelli, Roberto; Castellone, MARIA DOMENICA; Guida, Teresa; Annamaria, Cirafici; Francesco, Merolla; Livia, Provitera; Roberto, Limongello; Nina, Dathan; Grieco, Domenico; Costanzo, Vincenzo; Fusco, Alfredo; Santoro, Massimo; Carlomagno, Francesca
Molecular targeting of the RET kinase in thyroid cancer
2007 Santoro, Massimo; Carlomagno, F.
Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase.
2003 Fortunato, Ciardiello; Rosa, Caputo; Vincenzo, Damiano; Roberta, Caputo; Teresa, Troiani; Donatella, Vitagliano; Carlomagno, Francesca; Veneziani, BIANCA MARIA; Gabriella, Fontanini; A., Raffaele Bianco; Giampaolo, Tortora
Pros and cons of cellular studies in developing new drugs for thyroid cancers
2008 Salvatore, G.; Carlomagno, Francesca; Santoro, Massimo
Identification of Polo-like kinase 1 as a potential therapeutic target in anaplastic thyroid carcinoma.
2009 Nappi, T.; Salerno, P.; Zitzelsberger, H.; Carlomagno, Francesca; Salvatore, G.; Santoro, Massimo
Determination of the frequency of the common 657Del5 Nijmegen breakage syndrome mutation in the German population: no association with risk of breast cancer
1999 Carlomagno, Francesca; CHANG CLAUDE, J; Dunning, Am; Ponder, Baj
Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival
2000 DE VITA, Gabriella; Melillo, ROSA MARINA; Carlomagno, Francesca; Visconti, R; Castellone, Md; Bellacosa, A; Billaud, M; Fusco, Alfredo; Tsichlis, Pn; Santoro, M.
Constitutive and AP20187-induced Ret activation in photoreceptors does not protect from light-induced damage.
2007 Allocca, M; DI VICINO, U; Petrillo, M; Carlomagno, Francesca; Domenici, L; Auricchio, Alberto
Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
---|---|---|---|---|
Drug insight: Small-molecule inhibitors of protein kinases in the treatment of thyroid cancer. | 1.1 Articolo in rivista | 2006 | Santoro, Massimo; Carlomagno, Francesca | |
Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma | 1.1 Articolo in rivista | 2002 | F., Basolo; R., Giannini; C., Monaco; Melillo, ROSA MARINA; Carlomagno, Francesca; M., Pancrazi; G., Salvatore; G., Chiappetta; F., Pacini; R., Elisei; P., Miccoli; A., Pinchera; Fusco, Alfredo; Santoro, Massimo | |
The Insulin Receptor Substrate (IRS)-1 recruits Phosphatidylinositol 3-Kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to Ret. | 1.1 Articolo in rivista | 2001 | Melillo, ROSA MARINA; Carlomagno, Francesca; DE VITA, Gabriella; Formisano, Pietro; Vecchio, Giancarlo; Fusco, Alfredo; Billaud, M.; Santoro, Massimo | |
I geni oncosoppressori in "Patologia Generale" IV Ed, Pontieri-Russo-Frati | 3.1 Monografia o trattato scientifico | 2009 | Santoro, Massimo; Carlomagno, F; Vecchio, Giancarlo | |
Basi molecolari delle nuove terapie: inibitori delle protein-chinasi. | 2.1 Contributo in volume (Capitolo o Saggio) | 2007 | Santoro, Massimo; Salvatore, G.; Carlomagno, F.; Fusco, Alfredo | |
Activation of RET oncogene and thyroid carcinogenesis | 2.1 Contributo in volume (Capitolo o Saggio) | 1993 | Santoro, Massimo; Grieco, M.; Melillo, ROSA MARINA; Carlomagno, F.; Cerrato, A.; Sabino, N.; Battaglia, C.; Fusco, Alfredo; Vecchio, Giancarlo | |
RET\PTC activation in human thyroid carcinomas | 1.1 Articolo in rivista | 1995 | Fusco, Alfredo; Santoro, Massimo; Grieco, M.; Carlomagno, Francesca; Dathan, N.; Fabien, N.; Berlingieri, M. T.; Li, Z.; de franciscis, V.; Salvatore, Domenico; Melillo, ROSA MARINA; Portella, Giuseppe; Cerrato, A.; Colantuoni, V.; Vecchio, Giancarlo | |
Molecular Mechianism of RET Activation In Human Neoplasia | 2.1 Contributo in volume (Capitolo o Saggio) | 2002 | Santoro, Massimo; Carlomagno, F.; Melillo, ROSA MARINA; Vecchio, Giancarlo; Fusco, Alfredo | |
Molecular mechanisms of RET activation in human cancer. | 1.1 Articolo in rivista | 2002 | Santoro, Massimo; Melillo, ROSA MARINA; Carlomagno, Francesca; Fusco, Alfredo; Vecchio, Giancarlo | |
Attacking cancer with molecularly targeted agents | 1.1 Articolo in rivista | 2013 | Santoro, Massimo; Carlomagno, Francesca | |
Oncogenic rearrangements driving ionizing radiation-associated human cancer | 1.1 Articolo in rivista | 2013 | Santoro, Massimo; Carlomagno, Francesca | |
Structure prediction and validation of the ERK8 kinase domain. | 1.1 Articolo in rivista | 2013 | Strambi, A; Mori, M; Rossi, M; Colecchia, D; Manetti, F; Carlomagno, Francesca; Botta, M; Chiariello, M. | |
NCOA4 inhibits initiation of DNA replication to maintain genome stability | 4.2 Abstract in Atti di convegno | 2012 | Bellelli, Roberto; Castellone, MARIA DOMENICA; Guida, Teresa; Annamaria, Cirafici; Francesco, Merolla; Livia, Provitera; Roberto, Limongello; Nina, Dathan; Grieco, Domenico; Costanzo, Vincenzo; Fusco, Alfredo; Santoro, Massimo; Carlomagno, Francesca | |
Molecular targeting of the RET kinase in thyroid cancer | 8.02 Comunicazioni a Convegni o Seminari | 2007 | Santoro, Massimo; Carlomagno, F. | |
Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase. | 1.1 Articolo in rivista | 2003 | Fortunato, Ciardiello; Rosa, Caputo; Vincenzo, Damiano; Roberta, Caputo; Teresa, Troiani; Donatella, Vitagliano; Carlomagno, Francesca; Veneziani, BIANCA MARIA; Gabriella, Fontanini; A., Raffaele Bianco; Giampaolo, Tortora | |
Pros and cons of cellular studies in developing new drugs for thyroid cancers | 1.1 Articolo in rivista | 2008 | Salvatore, G.; Carlomagno, Francesca; Santoro, Massimo | |
Identification of Polo-like kinase 1 as a potential therapeutic target in anaplastic thyroid carcinoma. | 1.1 Articolo in rivista | 2009 | Nappi, T.; Salerno, P.; Zitzelsberger, H.; Carlomagno, Francesca; Salvatore, G.; Santoro, Massimo | |
Determination of the frequency of the common 657Del5 Nijmegen breakage syndrome mutation in the German population: no association with risk of breast cancer | 1.1 Articolo in rivista | 1999 | Carlomagno, Francesca; CHANG CLAUDE, J; Dunning, Am; Ponder, Baj | |
Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival | 1.1 Articolo in rivista | 2000 | DE VITA, Gabriella; Melillo, ROSA MARINA; Carlomagno, Francesca; Visconti, R; Castellone, Md; Bellacosa, A; Billaud, M; Fusco, Alfredo; Tsichlis, Pn; Santoro, M. | |
Constitutive and AP20187-induced Ret activation in photoreceptors does not protect from light-induced damage. | 1.1 Articolo in rivista | 2007 | Allocca, M; DI VICINO, U; Petrillo, M; Carlomagno, Francesca; Domenici, L; Auricchio, Alberto |